Rhabdomyolysis in allogeneic peripheral blood stem cell donors.
Schanz
J
J
Department of Transfusion Medicine, University of Goettingen, Goettingen, Germany. j.schanz@med.uni-goettingen.de
Wolf
C
C
Koehler
M
M
Maas
J H
JH
Meyer
M
M
Neumeyer
H
H
Legler
T J
TJ
Wulf
G
G
Glass
B
B
Truemper
L
L
Riggert
J
J
D000328:Adult; D015415:Biomarkers; D001782:Blood Donors; D003402:Creatine Kinase / Q000097:blood; D052283:Creatine Kinase, MM Form; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D019650:Hematopoietic Stem Cell Mobilization / Q000009:adverse effects*; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D000078224:Lenograstim; D008297:Male; D009211:Myoglobin / Q000097:blood; D010146:Pain / Q000139:chemically induced; D036102:Peripheral Blood Stem Cell Transplantation; D011994:Recombinant Proteins / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000097:blood / Q000139:chemically induced*
D015415:Biomarkers; D007527:Isoenzymes; D009211:Myoglobin; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000078224:Lenograstim; D003402:Creatine Kinase; D052283:Creatine Kinase, MM Form